A vulnerability of certain lung cancer cells that can be exploited for new therapies has been identified by physician-researchers at UT Southwestern Medical Center.
Although researchers have long known that mutant versions of the KRAS gene drive tumor formation and are key to cell survival in non-small cell lung cancer, the blocking of activated KRAS has proven difficult. For years, investigations have explored stopping lung cancer at this junction, which also would have an impact on many other cancers....
A vulnerability of certain lung cancer cells that can be exploited for new therapies has been identified by physician-researchers at UT Southwestern Medical Center.
Although researchers have long known that mutant versions of the KRAS gene drive tumor formation and are key to cell survival in non-small cell lung cancer, the blocking of activated KRAS has proven difficult. For years, investigations have explored stopping lung cancer at this junction, which also would have an impact on many other cancers....